Porton Pharma Solutions

CAS 915095-89-5

Chemistry, 11 End Use API, 78 Related Intermediates

Manufacturers/Suppliers

11 Suppliers

11 Suppliers

Also known as: 915095-89-5, (3s)-3-[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-furan, (3s)-3-[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]oxolane, 4wr8p4hz8g, (s)-3-(4-(5-bromo-2-chlorobenzyl)phenoxy) tetrahydrofuran, Furan, 3-[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-, (3s)-

Molecular Formula

C₁₇H₁₆BrClO₂

Molecular Weight

367.7 g/mol

InChI Key

HUNLNKBDQXGMAP-INIZCTEOSA-N

FDA UNII

4WR8P4HZ8G

1 2D Structure

CAS 915095-89-5

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(3S)-3-[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]oxolane

2.1.2 InChI

InChI=1S/C17H16BrClO2/c18-14-3-6-17(19)13(10-14)9-12-1-4-15(5-2-12)21-16-7-8-20-11-16/h1-6,10,16H,7-9,11H2/t16-/m0/s1

2.1.3 InChI Key

HUNLNKBDQXGMAP-INIZCTEOSA-N

2.1.4 Canonical SMILES

C1COCC1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)Br)Cl

2.1.5 Isomeric SMILES

C1COC[C@H]1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)Br)Cl

2.2 Other Identifiers

2.2.1 UNII

4WR8P4HZ8G

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. 915095-89-5

2. (3s)-3-[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-furan

3. (3s)-3-[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]oxolane

4. 4wr8p4hz8g

5. (s)-3-(4-(5-bromo-2-chlorobenzyl)phenoxy) Tetrahydrofuran

6. Furan, 3-[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-, (3s)-

7. Furan, 3-(4-((5-bromo-2-chlorophenyl)methyl)phenoxy)tetrahydro-, (3s)-

8. (3s)-3-{4-[(5-bromo-2-chlorophenyl)methyl]phenoxy}oxolane

9. Mfcd27920793

10. Unii-4wr8p4hz8g

11. Schembl2638119

12. Amy16484

13. Bcp11193

14. Zinc34775526

15. Akos022186156

16. Ds-7819

17. Ac-26974

18. Cs-0015036

19. (3s)-3-(4-((5-bromo-2-chlorophenyl)methyl)phenoxy)tetrahydrofuran

2.4 Create Date

2007-02-21

3 Chemical and Physical Properties

Molecular Formula	C₁₇H₁₆BrClO₂
Molecular Weight	367.7 g/mol
XLogP3	5.2
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	2
Rotatable Bond Count	4
Exact Mass	366.00222 g/mol
Monoisotopic Mass	366.00222 g/mol
Topological Polar Surface Area	18.5 Å²
Heavy Atom Count	21
Formal Charge	0
Complexity	320
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

List of Suppliers

Full Screen View

Reset Filter

Ask Us

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

China

Virtual Booth

Digital Content

(3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6- ((triMet...

PDF Supplier PDF

URL Supplier Web Content

CAS Number

32384-65-9

End Use API

Empagliflozin

About the Company

Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzh...

Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.

ASK
US